{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:02:12Z","timestamp":1791511332158,"version":"4.3.4"},"reference-count":131,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2017,7,29]],"date-time":"2017-07-29T00:00:00Z","timestamp":1501286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Normal pregnancy is a state of hypercoagulability with diminishing fibrinolytic activity, which is mainly caused by an increase of plasminogen activator inhibitor type 1 (PAI-1). PAI-1 is the main inhibitor of plasminogen activators, including tissue-type plasminogen activator (tPA) and urokinase-type plasminogen activator (uPA). In human placentas, PAI-1 is expressed in extravillous interstitial trophoblasts and vascular trophoblasts. During implantation and placentation, PAI-1 is responsible for inhibiting extra cellular matrix (ECM) degradation, thereby causing an inhibition of trophoblasts invasion. In the present study, we have reviewed the literature of various reproductive diseases where PAI-1 plays a role. PAI-1 levels are increased in patients with recurrent pregnancy losses (RPL), preeclampsia, intrauterine growth restriction (IUGR), gestational diabetes mellitus (GDM) in the previous pregnancy, endometriosis and polycystic ovary syndrome (PCOS). In general, an increased expression of PAI-1 in the blood is associated with an increased risk for infertility and a worse pregnancy outcome. GDM and PCOS are related to the genetic role of the 4G\/5G polymorphism of PAI-1. This review provides an overview of the current knowledge of the role of PAI-1 in reproductive diseases. PAI-1 represents a promising monitoring biomarker for reproductive diseases and may be a treatment target in the near future.<\/jats:p>","DOI":"10.3390\/ijms18081651","type":"journal-article","created":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T03:30:06Z","timestamp":1501558206000},"page":"1651","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":106,"title":["Role of Plasminogen Activator Inhibitor Type 1 in Pathologies of Female Reproductive Diseases"],"prefix":"10.3390","volume":"18","author":[{"given":"Yao","family":"Ye","sequence":"first","affiliation":[{"name":"Department of Gynaecology and Obstetrics, Ludwig-Maximilians University of Munich, Campus Gro\u00dfhadern: Marchioninistr. 15, 81377 Munich and Campus Innenstadt: Maistr. 11, 80337 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelia","family":"Vattai","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, Ludwig-Maximilians University of Munich, Campus Gro\u00dfhadern: Marchioninistr. 15, 81377 Munich and Campus Innenstadt: Maistr. 11, 80337 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, Ludwig-Maximilians University of Munich, Campus Gro\u00dfhadern: Marchioninistr. 15, 81377 Munich and Campus Innenstadt: Maistr. 11, 80337 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junyan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, Ludwig-Maximilians University of Munich, Campus Gro\u00dfhadern: Marchioninistr. 15, 81377 Munich and Campus Innenstadt: Maistr. 11, 80337 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Thaler","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, Ludwig-Maximilians University of Munich, Campus Gro\u00dfhadern: Marchioninistr. 15, 81377 Munich and Campus Innenstadt: Maistr. 11, 80337 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sven","family":"Mahner","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, Ludwig-Maximilians University of Munich, Campus Gro\u00dfhadern: Marchioninistr. 15, 81377 Munich and Campus Innenstadt: Maistr. 11, 80337 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2623-3235","authenticated-orcid":false,"given":"Udo","family":"Jeschke","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, Ludwig-Maximilians University of Munich, Campus Gro\u00dfhadern: Marchioninistr. 15, 81377 Munich and Campus Innenstadt: Maistr. 11, 80337 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktoria","family":"Von Sch\u00f6nfeldt","sequence":"additional","affiliation":[{"name":"Department of Gynaecology and Obstetrics, Ludwig-Maximilians University of Munich, Campus Gro\u00dfhadern: Marchioninistr. 15, 81377 Munich and Campus Innenstadt: Maistr. 11, 80337 Munich, Germany"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2017,7,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2174\/092986708783955455","article-title":"Fibrinolysis: The key to new pathogenetic mechanisms","volume":"15","author":"Zorio","year":"2008","journal-title":"Curr. Med. Chem."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1055\/s-2003-38897","article-title":"Hemostasis during normal pregnancy and puerperium","volume":"29","author":"Hellgren","year":"2003","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/0014-5793(85)81309-0","article-title":"Identification of a reversible inhibitor of plasminogen activators in blood plasma","volume":"190","author":"Kluft","year":"1985","journal-title":"FEBS Lett."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1055\/s-0038-1646006","article-title":"Plasminogen activator inhibitor-1 is the primary inhibitor of tissue-type plasminogen activator in pregnancy plasma","volume":"58","author":"Jorgensen","year":"1987","journal-title":"Thromb. Haemost."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1152\/physiolgenomics.00147.2010","article-title":"Transient reduction of placental angiogenesis in PAI-1-deficient mice","volume":"43","author":"Labied","year":"2011","journal-title":"Physiol. Genom."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1182\/blood.V90.1.204.204_204_208","article-title":"Human plasminogen activator inhibitor-1 (PAI-1) deficiency: Characterization of a large kindred with a null mutation in the PAI-1 gene","volume":"90","author":"Fay","year":"1997","journal-title":"Blood"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/hae.12313","article-title":"The obstetric, gynaecological and fertility implications of homozygous PAI-1 deficiency: Single-centre experience","volume":"20","author":"Heiman","year":"2014","journal-title":"Haemophilia"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1365-2141.2005.05444.x","article-title":"Molecular mechanisms of fibrinolysis","volume":"129","author":"Hajjar","year":"2005","journal-title":"Br. J. Haematol."},{"key":"ref_9","first-page":"858293","article-title":"Functional stability of plasminogen activator inhibitor-1","volume":"2014","author":"Kuru","year":"2014","journal-title":"Sci. World J."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/jcp.22783","article-title":"PAI-1 in tissue fibrosis","volume":"227","author":"Ghosh","year":"2012","journal-title":"J. Cell Physiol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1186\/s13058-014-0428-4","article-title":"uPA and PAI-1 as biomarkers in breast cancer: Validated for clinical use in level-of-evidence-1 studies","volume":"16","author":"Duffy","year":"2014","journal-title":"Breast Cancer Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.amjmed.2003.08.014","article-title":"Effect of plasminogen activator inhibitor-1 in diabetes mellitus and cardiovascular disease","volume":"115","author":"Lyon","year":"2003","journal-title":"Am. J. Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0950-3536(05)80268-9","article-title":"Mechanisms of physiological fibrinolysis","volume":"8","author":"Lijnen","year":"1995","journal-title":"Baillieres Clin. Haematol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1139\/y02-016","article-title":"Regulation of human trophoblast migration and invasiveness","volume":"80","author":"Chakraborty","year":"2002","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1083\/jcb.104.4.801","article-title":"Urokinase-type plasminogen activator: Proenzyme, receptor, and inhibitors","volume":"104","author":"Blasi","year":"1987","journal-title":"J. Cell Biol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"11189","DOI":"10.1016\/S0021-9258(18)37940-7","article-title":"One-chain urokinase-type plasminogen activator from human sarcoma cells is a proenzyme with little or no intrinsic activity","volume":"263","author":"Petersen","year":"1988","journal-title":"J. Biol. Chem."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.thromres.2004.08.004","article-title":"Haemostatic changes in pregnancy","volume":"114","author":"Brenner","year":"2004","journal-title":"Thromb. Res."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1160\/TH03-12-0764","article-title":"The structural basis for the pathophysiological relevance of PAI-1 in cardiovascular diseases and the development of potential PAI-1 inhibitors","volume":"91","author":"Gils","year":"2004","journal-title":"Thromb. Haemost."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s000180050497","article-title":"The plasminogen activation system in tumor growth, invasion, and metastasis","volume":"57","author":"Andreasen","year":"2000","journal-title":"Cell. Mol. Life Sci. CMLS"},{"key":"ref_20","first-page":"179","article-title":"The pathophysiological relevance of PAI-1 in cardiovascular diseases and the development of monoclonal antibodies as PAI-1 inhibitors","volume":"68","author":"Gils","year":"2006","journal-title":"Verh K Acad Geneeskd Belg"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/01.ATV.18.1.20","article-title":"Very-low-density lipoprotein response element in the promoter region of the human plasminogen activator inhibitor-1 gene implicated in the impaired fibrinolysis of hypertriglyceridemia","volume":"18","author":"Eriksson","year":"1998","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1146\/annurev.cb.04.110188.000521","article-title":"Cell-associated plasminogen activation: Regulation and physiological functions","volume":"4","author":"Saksela","year":"1988","journal-title":"Annu. Rev. Cell Biol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1055\/s-2007-996035","article-title":"Significance of the plasminogen activator inhibitor of placental type (PAI-2) in pregnancy","volume":"24","author":"Astedt","year":"1998","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"4007","DOI":"10.1182\/blood.V86.11.4007.bloodjournal86114007","article-title":"Biological and clinical aspects of plasminogen activator inhibitor type 2","volume":"86","author":"Kruithof","year":"1995","journal-title":"Blood"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1111\/j.1538-7836.2008.03181.x","article-title":"The multi-functional serpin, protein C inhibitor: Beyond thrombosis and hemostasis","volume":"6","author":"Suzuki","year":"2008","journal-title":"J. Thromb. Haemost."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1182\/blood.V69.2.460.460","article-title":"Fibrinolysis in pregnancy: A study of plasminogen activator inhibitors","volume":"69","author":"Kruithof","year":"1987","journal-title":"Blood"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1055\/s-0038-1661167","article-title":"Haemostasis in normal pregnancy","volume":"52","author":"Stirling","year":"1984","journal-title":"Thromb. Haemost."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S0002-9378(94)70246-2","article-title":"Immunohistochemical localization of urokinase-type plasminogen activator and the plasminogen activator inhibitors 1 and 2 in early human implantation sites","volume":"170","author":"Hofmann","year":"1994","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_29","first-page":"20","article-title":"Plasminogen activator inhibitor types 1 and 2 in human trophoblasts. PAI-1 is an immunocytochemical marker of invading trophoblasts","volume":"61","author":"Feinberg","year":"1989","journal-title":"Lab. Investig. J. Tech. Methods Pathol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1053\/plac.2000.0573","article-title":"Does plasminogen activator inhibitor-1 (PAI-1) control trophoblast invasion? A study of fetal and maternal tissue in intrauterine, tubal and molar pregnancies","volume":"21","author":"Floridon","year":"2000","journal-title":"Placenta"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1046\/j.1469-7580.1999.19420183.x","article-title":"Expression of tissue type and urokinase type plasminogen activators as well as plasminogen activator inhibitor type-1 and type-2 in human and rhesus monkey placenta","volume":"194","author":"Hu","year":"1999","journal-title":"J. Anat."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.placenta.2009.02.002","article-title":"The urokinase plasminogen activator (uPA) system in uterine natural killer cells in the placental bed during early pregnancy","volume":"30","author":"Naruse","year":"2009","journal-title":"Placenta"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/19336918.2015.1120397","article-title":"Intrauterine trophoblast migration: A comparative view of humans and rodents","volume":"10","author":"Silva","year":"2016","journal-title":"Cell Adh. Migr."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1139\/y02-006","article-title":"Human placental trophoblast as an in vitro model for tumor progression","volume":"80","author":"Lala","year":"2002","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1006\/excr.1998.4240","article-title":"Stimulation of plasminogen activator inhibitor-1 expression in immortalized human trophoblast cells cultured under low levels of oxygen","volume":"245","author":"Fitzpatrick","year":"1998","journal-title":"Exp. Cell Res."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.biocel.2006.10.008","article-title":"Urokinase-type plasminogen activator","volume":"39","author":"Crippa","year":"2007","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1095\/biolreprod.105.047332","article-title":"Low oxygen concentrations inhibit trophoblast cell invasion from early gestation placental explants via alterations in levels of the urokinase plasminogen activator system","volume":"74","author":"Lash","year":"2006","journal-title":"Biol. Reprod."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"24601","DOI":"10.1074\/jbc.M201369200","article-title":"Angiotensin II inhibits human trophoblast invasion through AT1 receptor activation","volume":"277","author":"Xia","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1210\/jc.2003-031351","article-title":"Tumor necrosis factor-\u03b1 inhibits trophoblast migration through elevation of plasminogen activator inhibitor-1 in first-trimester villous explant cultures","volume":"89","author":"Bauer","year":"2004","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Estella, C., Herrer, I., Atkinson, S.P., Quinonero, A., Martinez, S., Pellicer, A., and Simon, C. (2012). Inhibition of histone deacetylase activity in human endometrial stromal cells promotes extracellular matrix remodelling and limits embryo invasion. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0030508"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0014-5793(01)02797-1","article-title":"PAI-1 inhibits urokinase-induced chemotaxis by internalizing the urokinase receptor","volume":"505","author":"Degryse","year":"2001","journal-title":"FEBS Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1091\/mbc.12.5.1467","article-title":"Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity","volume":"12","author":"Czekay","year":"2001","journal-title":"Mol. Biol. Cell"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"22595","DOI":"10.1074\/jbc.M313004200","article-title":"The low density lipoprotein receptor-related protein is a motogenic receptor for plasminogen activator inhibitor-1","volume":"279","author":"Degryse","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1046\/j.1523-1747.2003.12564.x","article-title":"Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts","volume":"121","author":"Zhang","year":"2003","journal-title":"J. Investig. Dermatol."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1095\/biolreprod.104.038000","article-title":"Activated macrophages inhibit human cytotrophoblast invasiveness in vitro","volume":"73","author":"Renaud","year":"2005","journal-title":"Biol. Reprod."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.placenta.2005.02.012","article-title":"TNF\u03b1-mediated induction of PAI-1 restricts invasion of HTR-8\/SVneo trophoblast cells","volume":"27","author":"Huber","year":"2006","journal-title":"Placenta"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1053\/plac.1999.0446","article-title":"Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation","volume":"21","author":"Feng","year":"2000","journal-title":"Placenta"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1387\/ijdb.140083ms","article-title":"Adaptive mechanisms controlling uterine spiral artery remodeling during the establishment of pregnancy","volume":"58","author":"Soares","year":"2014","journal-title":"Int. J. Dev. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1095\/biolreprod.102.014977","article-title":"Endovascular trophoblast invasion: Implications for the pathogenesis of intrauterine growth retardation and preeclampsia","volume":"69","author":"Kaufmann","year":"2003","journal-title":"Biol. Reprod."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"33964","DOI":"10.1074\/jbc.M105980200","article-title":"Plasminogen activator inhibitor-1 regulates tumor growth and angiogenesis","volume":"276","author":"McMahon","year":"2001","journal-title":"J. Biol. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/0140-6736(90)92159-F","article-title":"Recurrent miscarriage","volume":"336","author":"Stirrat","year":"1990","journal-title":"Lancet"},{"key":"ref_52","unstructured":"Practice Committee of the American Society for Reproductive Medicine (2013). Definitions of infertility and recurrent pregnancy loss: A committee opinion. Fertil. Steril."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/S0140-6736(06)69204-0","article-title":"Recurrent miscarriage","volume":"368","author":"Rai","year":"2006","journal-title":"Lancet"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.fertnstert.2009.01.166","article-title":"Diagnostic factors identified in 1020 women with two versus three or more recurrent pregnancy losses","volume":"93","author":"Jaslow","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_55","first-page":"606","article-title":"Plasma fibrinolytic activators and their inhibitors in women suffering from early recurrent abortion of unknown etiology","volume":"122","author":"Gris","year":"1993","journal-title":"J. Lab. Clin. Med."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1055\/s-0038-1656119","article-title":"Respective evaluation of the prevalence of haemostasis abnormalities in unexplained primary early recurrent miscarriages. The Nimes Obstetricians and Haematologists (NOHA) Study","volume":"77","author":"Gris","year":"1997","journal-title":"Thromb. Haemost."},{"key":"ref_57","first-page":"1051","article-title":"Meta-analysis of the association between plasminogen activator inhibitor-1 4G\/5G polymorphism and recurrent pregnancy loss","volume":"21","author":"Li","year":"2015","journal-title":"Med. Sci. Monit. Int. Med. J. Exp. Clin. Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s10815-013-0125-8","article-title":"Association between plasminogen activator inhibitor 1 gene mutation and different subgroups of recurrent miscarriage and implantation failure","volume":"31","author":"Khosravi","year":"2014","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/j.1600-0897.2009.00744.x","article-title":"Are polymorphisms in the ACE and PAI-1 genes associated with recurrent spontaneous miscarriages?","volume":"62","author":"Goodman","year":"2009","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1160\/TH12-08-0584","article-title":"Genetic association studies of ACE and PAI-1 genes in women with recurrent pregnancy loss: A systematic review and meta-analysis","volume":"109","author":"Su","year":"2013","journal-title":"Thromb. Haemost."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1600-0897.2006.00376.x","article-title":"Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage","volume":"55","author":"Coulam","year":"2006","journal-title":"Am. J. Reprod. Immunol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s10815-013-0071-5","article-title":"The association between thrombophilic gene mutations and recurrent pregnancy loss","volume":"30","author":"Chaparzadeh","year":"2013","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1093\/humrep\/deg474","article-title":"Polymorphisms in the ACE and PAI-1 genes are associated with recurrent spontaneous miscarriages","volume":"18","author":"Buchholz","year":"2003","journal-title":"Hum. Reprod."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1126\/science.1111726","article-title":"Latest advances in understanding preeclampsia","volume":"308","author":"Redman","year":"2005","journal-title":"Science"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ajog.2008.07.048","article-title":"Diagnosis and management of atypical preeclampsia-eclampsia","volume":"200","author":"Sibai","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.placenta.2008.06.011","article-title":"The functional role of the renin-angiotensin system in pregnancy and preeclampsia","volume":"29","author":"Irani","year":"2008","journal-title":"Placenta"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1155\/2011\/219350","article-title":"Fibronectin, plasminogen activator inhibitor type 1 (PAI-1) and uterine artery Doppler velocimetry as markers of preeclampsia","volume":"30","author":"Bodova","year":"2011","journal-title":"Dis. Mark."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1373\/clinchem.2006.081372","article-title":"Cell-free mRNA concentrations of plasminogen activator inhibitor-1 and tissue-type plasminogen activator are increased in the plasma of pregnant women with preeclampsia","volume":"53","author":"Purwosunu","year":"2007","journal-title":"Clin. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/j.ajog.2009.06.024","article-title":"Evidence of increased oxidative stress and a change in the plasminogen activator inhibitor (PAI)-1 to PAI-2 ratio in early-onset but not late-onset preeclampsia","volume":"201","author":"Wikstrom","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1182\/blood.V74.4.1332.1332","article-title":"Changes in the plasma levels of type 1 and type 2 plasminogen activator inhibitors in normal pregnancy and in patients with severe preeclampsia","volume":"74","author":"Estelles","year":"1989","journal-title":"Blood"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3109\/10641950903242675","article-title":"Maternal plasma plasminogen activator inhibitor-2 at 11 to 13 weeks of gestation in hypertensive disorders of pregnancy","volume":"30","author":"Akolekar","year":"2011","journal-title":"Hypertens. Pregnancy"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.thromres.2008.02.007","article-title":"Relationship between maternal and cord blood hemostatic disturbances in preeclamptic pregnancies","volume":"123","author":"Catarino","year":"2008","journal-title":"Thromb. Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"43667","DOI":"10.18632\/oncotarget.6190","article-title":"Cigarette smoking during pregnancy and preeclampsia risk: A systematic review and meta-analysis of prospective studies","volume":"6","author":"Wei","year":"2015","journal-title":"Oncotarget"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1046\/j.1365-2141.1997.d01-2137.x","article-title":"The effects of chronic smoking on the fibrinolytic potential of plasma and platelets","volume":"97","author":"Simpson","year":"1997","journal-title":"Br. J. Haematol."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/j.1538-7836.2012.04700.x","article-title":"The PAI-1 4G\/5G polymorphism is not associated with an increased risk of adverse pregnancy outcome in asymptomatic nulliparous women","volume":"10","author":"Said","year":"2012","journal-title":"J. Thromb. Haemost."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1002\/jcp.22907","article-title":"Possible role of RKIP in cytotrophoblast migration: Immunohistochemical and in vitro studies","volume":"227","author":"Ciarmela","year":"2012","journal-title":"J. Cell. Physiol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.placenta.2012.05.008","article-title":"The role of interleukin-1\u03b2 in human trophoblast motility","volume":"33","author":"Prutsch","year":"2012","journal-title":"Placenta"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/molehr\/gah031","article-title":"Vascular endothelial growth factor, epidermal growth factor and fibroblast growth factor-4 and -10 stimulate trophoblast plasminogen activator system and metalloproteinase-9","volume":"10","author":"Anteby","year":"2004","journal-title":"Mol. Hum. Reprod."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.placenta.2007.04.005","article-title":"Role of hypoxia-inducible transcription factors 1\u03b1 and 2\u03b1 in the regulation of plasminogen activator inhibitor-1 expression in a human trophoblast cell line","volume":"28","author":"Meade","year":"2007","journal-title":"Placenta"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.thromres.2009.05.016","article-title":"Role of the syncytium in placenta-mediated complications of preeclampsia","volume":"124","author":"Guller","year":"2009","journal-title":"Thromb. Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1538-7836.2005.01226.x","article-title":"The G20210A prothrombin-gene mutation and the plasminogen activator inhibitor (PAI-1) 5G\/5G genotype are associated with early onset of severe preeclampsia","volume":"3","author":"Gerhardt","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Morgan, J.A., Bombell, S., and McGuire, W. (2013). Association of plasminogen activator inhibitor-type 1 (-675 4G\/5G) polymorphism with pre-eclampsia: Systematic review. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0056907"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s40748-016-0041-x","article-title":"Early onset fetal growth restriction","volume":"3","author":"Brunelli","year":"2017","journal-title":"Matern. Health Neonatol. Perinat."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"7124186","DOI":"10.1155\/2016\/7124186","article-title":"Increased Umbilical Cord PAI-1 Levels in Placental Insufficiency Are Associated with Fetal Hypoxia and Angiogenesis","volume":"2016","author":"Seferovic","year":"2016","journal-title":"Dis. Markers"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/S0002-9378(00)70513-8","article-title":"Morbidity and mortality among very-low-birth-weight neonates with intrauterine growth restriction. The Vermont Oxford Network","volume":"182","author":"Bernstein","year":"2000","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/er.2005-0011","article-title":"Endocrine regulation of human fetal growth: The role of the mother, placenta, and fetus","volume":"27","author":"Murphy","year":"2006","journal-title":"Endocr. Rev."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"3453","DOI":"10.1113\/jphysiol.2009.173252","article-title":"Intrauterine growth restriction, human placental development and trophoblast cell death","volume":"587","author":"Scifres","year":"2009","journal-title":"J. Physiol."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1055\/s-2007-994947","article-title":"Uteroplacental hemostasis in intrauterine fetal growth retardation","volume":"25","author":"Sheppard","year":"1999","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1182\/blood.V84.1.143.143","article-title":"Altered expression of plasminogen activator inhibitor type 1 in placentas from pregnant women with preeclampsia and\/or intrauterine fetal growth retardation","volume":"84","author":"Estelles","year":"1994","journal-title":"Blood"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1097\/AOG.0b013e318256187f","article-title":"Angiogenic and fibrinolytic factors in blood during the first half of pregnancy and adverse pregnancy outcomes","volume":"119","author":"Coolman","year":"2012","journal-title":"Obstet. Gynecol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1159\/000292470","article-title":"Evaluation of plasminogen activators and plasminogen activator inhibitors in plasma and amniotic fluid in pregnancies complicated with intrauterine fetal growth retardation","volume":"38","author":"Gilabert","year":"1994","journal-title":"Gynecol. Obstet. Investig."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0002-9378(89)90096-3","article-title":"Enhanced thrombin generation in normal and hypertensive pregnancy","volume":"160","author":"Sturk","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/0002-9378(91)90242-J","article-title":"Fibrinolytic parameters in normotensive pregnancy with intrauterine fetal growth retardation and in severe preeclampsia","volume":"165","author":"Estelles","year":"1991","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/01.ede.0000158199.64871.b9","article-title":"Thrombophilic polymorphisms and intrauterine growth restriction","volume":"16","author":"Rivard","year":"2005","journal-title":"Epidemiology"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1447-0756.2010.01262.x","article-title":"Double inherited thrombophilias and adverse pregnancy outcomes: Fashion or science?","volume":"36","author":"Larciprete","year":"2010","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1365-2265.2011.04234.x","article-title":"Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia","volume":"76","author":"Miehle","year":"2012","journal-title":"Clin. Endocrinol."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"26","DOI":"10.3904\/kjim.2016.203","article-title":"Prevention of type 2 diabetes mellitus in women with previous gestational diabetes mellitus","volume":"32","author":"Moon","year":"2017","journal-title":"Korean J. Intern. Med."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"549748","DOI":"10.1155\/2012\/549748","article-title":"Role of adipokines and other inflammatory mediators in gestational diabetes mellitus and previous gestational diabetes mellitus","volume":"2012","author":"Vrachnis","year":"2012","journal-title":"Int. J. Endocrinol."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1210\/jc.2003-030241","article-title":"Insulin resistance and its potential role in pregnancy-induced hypertension","volume":"88","author":"Seely","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1755-5922.2010.00171.x","article-title":"Plasminogen activator inhibitor-1 (PAI-1): A key factor linking fibrinolysis and age-related subclinical and clinical conditions","volume":"28","author":"Cesari","year":"2010","journal-title":"Cardiovasc. Ther."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1024\/0301-1526\/a000171","article-title":"Arterial stiffness, inflammatory and pro-atherogenic markers in gestational diabetes mellitus","volume":"41","author":"Salmi","year":"2012","journal-title":"Vasa"},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Bugatto, F., Quintero-Prado, R., Visiedo, F.M., Vilar-Sanchez, J.M., Figueroa-Quinones, A., Lopez-Tinoco, C., Torrejon, R., and Bartha, J.L. (2017). The influence of lipid and proinflammatory status on maternal uterine blood flow in women with late onset gestational diabetes. Reprod. Sci.","DOI":"10.1177\/1933719117698576"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/cen.12325","article-title":"Maternal, umbilical arterial and umbilical venous 25-hydroxyvitamin D and adipocytokine concentrations in pregnancies with and without gestational diabetes","volume":"80","author":"McManus","year":"2014","journal-title":"Clin. Endocrinol."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1365-2362.2006.01630.x","article-title":"Fibrinolytic dysfunction in insulin-resistant women with previous gestational diabetes","volume":"36","author":"Farhan","year":"2006","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.diabres.2007.04.013","article-title":"Fibrinolytic dysfunction after gestation is associated to components of insulin resistance and early type 2 diabetes in latino women with previous gestational diabetes","volume":"78","author":"Morimitsu","year":"2007","journal-title":"Diabetes Res. Clin. Pract."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1210\/jc.2010-1662","article-title":"Inflammatory mediators and glucose in pregnancy: Results from a subset of the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study","volume":"95","author":"Lowe","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ajog.2014.04.033","article-title":"Hyperglycemia impairs cytotrophoblast function via stress signaling","volume":"211","author":"Cawyer","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/01.AOG.0000199953.27961.f9","article-title":"Plasminogen activator inhibitor 1 gene polymorphism and gestational diabetes mellitus","volume":"107","author":"Leipold","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1249\/MSS.0b013e318285402b","article-title":"Accelerometry-measured physical activity and inflammation after gestational diabetes","volume":"45","author":"Gingras","year":"2013","journal-title":"Med. Sci. Sports Exerc."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/meta.2000.6749","article-title":"The 4G\/4G polymorphism of the hypofibrinolytic plasminogen activator inhibitor type 1 gene: An independent risk factor for serious pregnancy complications","volume":"49","author":"Glueck","year":"2000","journal-title":"Metabolism"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"R63","DOI":"10.1530\/REP-16-0052","article-title":"Endometriosis: Where are we and where are we going?","volume":"152","author":"Greene","year":"2016","journal-title":"Reproduction"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.fertnstert.2004.09.033","article-title":"Basal release of urokinase plasminogen activator, plasminogen activator inhibitor-1, and soluble plasminogen activator receptor from separated and cultured endometriotic and endometrial stromal and epithelial cells","volume":"83","author":"Bruse","year":"2005","journal-title":"Fertil. Steril."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1093\/humrep\/deg300","article-title":"Expression of several components of the plasminogen activator and matrix metalloproteinase systems in endometriosis","volume":"18","author":"Estelles","year":"2003","journal-title":"Hum. Reprod."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.thromres.2008.02.010","article-title":"Plasminogen activator inhibitor-1 (PAI-1) 4G\/5G polymorphism and endometriosis. Influence of PAI-1 polymorphism on PAI-1 antigen and mRNA expression","volume":"122","author":"Ramon","year":"2008","journal-title":"Thromb. Res."},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.ejogrb.2009.06.008","article-title":"Plasminogen activator inhibitor-1 4G\/5G polymorphism and susceptibility to endometriosis in the Italian population","volume":"146","author":"Gentilini","year":"2009","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1600-0412.2011.01086.x","article-title":"Plasminogen activator inhibitor-1 4G\/5G polymorphism in infertile women with and without endometriosis","volume":"90","author":"Brandes","year":"2011","journal-title":"Acta Obstet. Gynecol. Scand."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: Etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"559","DOI":"10.14310\/horm.2002.1444","article-title":"Disparate effects of pharmacotherapy on plasma plasminogen activator inhibitor-1 levels in women with the polycystic ovary syndrome","volume":"12","author":"Koiou","year":"2013","journal-title":"Hormones"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1507\/endocrj.EJ11-0023","article-title":"Plasma plasminogen activator inhibitor-1 levels in the different phenotypes of the polycystic ovary syndrome","volume":"59","author":"Koiou","year":"2012","journal-title":"Endocr. J."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S1472-6483(10)61634-3","article-title":"Is plasminogen activator inhibitor-1 a cardiovascular risk factor in young women with polycystic ovary syndrome?","volume":"9","author":"Orio","year":"2004","journal-title":"Reprod. Biomed. Online"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1507\/endocrj.51.467","article-title":"The plasminogen activator system in young and lean women with polycystic ovary syndrome","volume":"51","author":"Tarkun","year":"2004","journal-title":"Endocr. J."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.fertnstert.2005.04.021","article-title":"Plasminogen activator inhibitor 1 and miscarriage after metformin treatment and laparoscopic ovarian drilling in patients with polycystic ovary syndrome","volume":"84","author":"Palomba","year":"2005","journal-title":"Fertil. Steril."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.fertnstert.2011.09.024","article-title":"Consensus on women\u2019s health aspects of polycystic ovary syndrome (PCOS): The Amsterdam ESHRE\/ASRM-Sponsored 3rd PCOS Consensus Workshop Group","volume":"97","author":"Fauser","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.2741\/1487","article-title":"Plasminogen activator\/plasminogen activator inhibitors in ovarian physiology","volume":"9","author":"Liu","year":"2004","journal-title":"Front. Biosci."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3109\/09513590009167677","article-title":"Immunohistochemical detection of plasminogen activator inhibitor-1 in polycystic ovaries","volume":"14","author":"Atiomo","year":"2000","journal-title":"Gynecol. Endocrinol."},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0026-0495(99)90250-0","article-title":"Plasminogen activator inhibitor activity: An independent risk factor for the high miscarriage rate during pregnancy in women with polycystic ovary syndrome","volume":"48","author":"Glueck","year":"1999","journal-title":"Metabolism"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2337\/diabetes.55.02.06.db05-1041","article-title":"Hemostatic markers of endothelial dysfunction and risk of incident type 2 diabetes: The Framingham Offspring Study","volume":"55","author":"Meigs","year":"2006","journal-title":"Diabetes"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.1161\/CIRCULATIONAHA.105.557132","article-title":"Which hemostatic markers add to the predictive value of conventional risk factors for coronary heart disease and ischemic stroke? The Caerphilly Study","volume":"112","author":"Smith","year":"2005","journal-title":"Circulation"},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"17714","DOI":"10.1038\/srep17714","article-title":"Plasminogen activator inhibitor-1 and type 2 diabetes: A systematic review and meta-analysis of observational studies","volume":"6","author":"Yarmolinsky","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"936","DOI":"10.3109\/09513590.2013.819086","article-title":"Correlation between plasminogen activator inhibitor-1 (PAI-1) promoter 4G\/5G polymorphism and metabolic\/proinflammatory factors in polycystic ovary syndrome","volume":"29","author":"Sales","year":"2013","journal-title":"Gynecol. Endocrinol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejogrb.2013.12.030","article-title":"Plasminogen activator inhibitor-1 4G\/5G and the MTHFR 677C\/T polymorphisms and susceptibility to polycystic ovary syndrome: A meta-analysis","volume":"175","author":"Lee","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/8\/1651\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T18:44:29Z","timestamp":1760208269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/18\/8\/1651"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,29]]},"references-count":131,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2017,8]]}},"alternative-id":["ijms18081651"],"URL":"https:\/\/doi.org\/10.3390\/ijms18081651","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,29]]}}}